FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-04-24
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:27
Label at a glance#
ProductFLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4%
Active ingredientIBUPROFEN, ITRACONAZOLE, TERBINAFINE, FLUCONAZOLE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC adverse reactions.
Active, inactive
NDC 72934-4176-9 FLUCONAZOLE USP 4% / IBUPROFEN USP 2% / ITRACONAZOLE USP 1% / TERBINAFINE HCL USP 4%. Solution 15gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| FLUCONAZOLE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| ITRACONAZOLE Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20190118 |
| TERBINAFINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-4176-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-449d-a910-e053-dadaa90a0b85 | FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-4176-9 | FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4% | 15 g in 1 VIAL, GLASS | SOLUTION | 15 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-4176 | FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4% SOLUTION [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190501_87480522-a42c-5023-e053-2995a90afd30.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-4176-9 | GM - Gram | 72934-4176 | e6135fb4-e4b2-4cd3-be82-fc59e5e51e33 | 1 | 2020-03-10 |
Products#
Every source-derived product name is available through these pages.
- FLUCONAZOLE 4% / IBUPROFEN 2% / ITRACONAZOLE 1% / TERBINAFINE HCL 4%
- IBUPROFEN
- ITRACONAZOLE
- TERBINAFINE
- FLUCONAZOLE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-4176 | 72934-4176-9 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IBUPROFEN | WK2XYI10QM | ACTIB |
| ITRACONAZOLE | 304NUG5GF4 | ACTIB |
| TERBINAFINE | G7RIW8S0XP | ACTIB |
| FLUCONAZOLE | 8VZV102JFY | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 87480522-a42d-5023-e053-2995a90afd30 | 87480522-a42c-5023-e053-2995a90afd30 | 2019-04-24 | Adverse reactions | 87480522-a42d-5023-e053-2995a90afd30 87480522-a42c-5023-e053-2995a90afd30 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


